Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.

[1]  A. Gressner,et al.  Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. , 2004, Clinical chemistry.

[2]  G. Dallinga-Thie,et al.  Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype , 2004, Circulation.

[3]  J. K. Dunn,et al.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  G. Lewis,et al.  Acute Effects of Insulin in the Control of VLDL Production in Humans: Implications for the insulin-resistant state , 1996, Diabetes Care.

[5]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[6]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.

[7]  G. Watts,et al.  Dyslipidemia in Visceral Obesity , 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[8]  G. Lewis.  Fatty acid regulation of very low density lipoprotein production. , 1997, Current opinion in lipidology.

[9]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[10]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[11]  S. Toubro,et al.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[12]  H C Lukaski,et al.  Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.

[13]  H. Ginsberg,et al.  The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis , 2000, Journal of cardiovascular risk.

[14]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[16]  P. Scherer,et al.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. , 2002, Diabetes.

[17]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[18]  A. Cooper.  Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.

[19]  Christine M. Williams,et al.  Apolipoprotein B-48: comparison of fasting concentrations measured in normolipidaemic individuals using SDS-PAGE, immunoblotting and ELISA. , 2004, Atherosclerosis.

[20]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[21]  J. Després,et al.  Dyslipidaemia and obesity. , 1994, Bailliere's clinical endocrinology and metabolism.

[22]  Y. Aggoun,et al.  Obesity, Metabolic Syndrome, and Cardiovascular Disease , 2007, Pediatric Research.

[23]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[24]  R. Vigneri,et al.  Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  P. Havel.  Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. , 2004, Diabetes.

[26]  大橋 浩二.  Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease , 2017 .

[27]  H. Ginsberg.  New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism , 2002, Circulation.

[28]  E. Rimm,et al.  Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. , 2004, Diabetes care.

[29]  K. Kugiyama,et al.  Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. , 2004, Journal of the American College of Cardiology.

[30]  S. Proctor,et al.  A Highly Sensitive Assay for Quantitation of Apolipoprotein B48 Using an Antibody to Human Apolipoprotein B and Enhanced Chemiluminescence , 1997, Annals of clinical biochemistry.

[31]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[32]  F. Riches,et al.  Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity , 1998, International Journal of Obesity.

[33]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[34]  B. Wajchenberg.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[35]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  G. Watts,et al.  Adipose tissue compartments and insulin resistance in overweight-obese Caucasian men. , 2004, Diabetes research and clinical practice.

[37]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[38]  G. Watts,et al.  Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. , 2002, Clinical chemistry.

[39]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[40]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.